Home > Maligne hematologie > Lymfoïde ziekten > Hodgkin lymfoom > RADAR

RADAR

A randomized phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previously untreated stage IA/IIA Hodgkin lymphoma.

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 14-12-2024, 23:33